% | $
Quotes you view appear here for quick access.

Cadence Pharmaceuticals, AŞ Message Board

  • jack_mlyn jack_mlyn Mar 28, 2013 5:26 PM Flag

    Give opinions on these thoughts

    for a one product company with no catalysts to have moved up so much ahead of a major event (the Ofirmev patent trial, which starts on May 20) has been perplexing. I wouldn't want to own it ahead of the trial - the litigation has been moving forward and trial will likely not be delayed. My "settlement" scenario valuation, which would be a best case scenario in which CADX settles with generic challenger Exela on the same terms as the PRGO settlement, is ~$5.50. I really can't see upside in any scenario other than a takeout, which is difficult to predict...